Multisorb Technologies to exhibit at 2014 AACC
Discussions will be held on the use of its sorbent products and systems to protect the integrity of and provide chemical and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
IDMA’s writ petition results in relief for the nutra sector
IDMA briefing on impact of Mumbai HC order quashing FSSAI advisory
NPPA’s arbitrary and unilateral action has shocked the industry: Dr Shailesh Ayyangar, President,…
Urge the Government to revisit this decision and help to build a more collaborative environment
Glenmark Generics receives approval for Fluocinonide cream
Glenmark Generics receives approval for Fluocinonide cream
Sanofi Pasteur publishes results of phase III dengue vaccine efficacy study
88.5 per cent reduction of dengue haemorrhagic fever shown in detailed analyses
Abbott to sell its developed markets branded generics pharma business to Mylan
The business to be sold operates in Europe, Japan, Canada, Australia and New Zealand and includes approximately 3,800 employees
Merck Serono appoints Luciano Rossetti as Global Head of R&D
He will be based in Billerica, outside Boston, Massachusetts (US)
Students of Principal KM Kundnani College of Pharmacy celebrate Silver Jubilee
The function was attended by a large number of staff and students both from India and abroad
WACKER opens logistics centre at Amtala Production Site near kolkata
The high-bay warehouse has a capacity of 5000 pallet spaces and will be operated by WMC
ABLE conducts BIRAC supported series at University of Rajasthan
The aim of the programme was to motivate the young student community, to instil and incite creative minds to build new ventures…
Merck Serono’s global grants programme to fund scientific innovation
The programme combines grants portfolio with annual €20 million investment to advance innovation and medical education
Glenmark Generics receives final ANDA approval for Telmisartan tablets
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis
Cipla plans investment in its UK subsidiary
The investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral medicines
US FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma
Also receives orphan product designation by the FDA because it is intended to treat a rare disease or condition
DHL adds India to the Thermonet network
The facilities in Mumbai, Bengaluru and Hyderabad are audited according to globally defined GDP to ensure conformity across the…
Glenmark’s novel monoclonal antibody GBR 830 enters human trials
GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting…
Glenmark and JJ gain entry in Guinness World Record on Doctor’s Day
Creates 66,311 bottles mosaic of an expectorant brand in the shape of a smile
Bharat Biotech donates REGEN-D to victims of AP gas explosion
Donates 500 tubes of REGEN-D to AP Chief Minister’s Relief Fund
PWC’s budget expectations
'Allow tax holiday for a period of 10 year indigenously developed biopharma drugs'- Sujay Shetty, Leader - Pharma and Life…
Actavis completes Forest Laboratories acquisition
Creates an innovative new model in specialty pharmaceuticals leadership